(Hypertension. 2000;36:760.)
© 2000 American Heart Association, Inc.
Scientific Contributions |
From the Laboratory for Physiology (P.S., N.W.), Institute for Cardiovascular Research, Free University of Amsterdam, the Netherlands; and Biomedical Engineering Laboratory (N.S.), EPFL, Lausanne, Switzerland.
Correspondence to Dr Patrick Segers, Laboratory for Physiology, Institute for Cardiovascular Research, Free University of Amsterdam, Van Der Boechorstlaan 7, 1081 BT Amsterdam, the Netherlands. E-mail patrick.segers{at}navier.rug.ac.be
| Abstract |
|---|
|
|
|---|
Key Words: hypertrophy arteries compliance models remodeling
| Introduction |
|---|
|
|
|---|
Blood pressure in hypertension, measured in vivo, reflects the combined effects of alterations in cardiac and arterial parameters. In this work, we use a mathematical heartarterial interaction model1 to unravel and quantify the specific contribution of arterial and cardiac changes. Cardiac and arterial model parameters for normotensive control subjects and for hypertensive patients with different LV adaptation patterns were taken directly from the literature or calculated from data given in the literature.3 The effect of individual changes in arterial and cardiac properties in hypertension was evaluated, and the relative contribution of cardiac and arterial remodeling to the increase in SBP was quantitatively assessed.
| Methods |
|---|
|
|
|---|
|
Estimation of Model Parameters
Values of R for control subjects and hypertensives are taken
from a clinical study by Ganau et al.3 Hypertensives are
classified according to 4 different LV adaptation patterns: normal LV
(LV mass index <111 g/m2 in men and 106
g/m2 in women and relative LV wall thickness of
<0.44), concentric remodeling (normal LV mass index but elevated
relative LV wall thickness), concentric hypertrophy (both
LV mass index and relative LV wall thickness elevated), or eccentric
hypertrophy (elevated LV mass index but normal relative LV
wall thickness) (for details, see Ganau et al3 ). Total
arterial compliance is calculated from given pressure and
flow data as follows. Stroke volume (SV) is given, and PP is calculated
as the difference between SBP and diastolic blood pressure
(DBP). The ratio of SV to PP is a measure of compliance but tends to
overestimate windkessel compliance by a factor of
1.6 in
dogs7 ; we therefore estimate C as 0.64 times SV/PP. In
control subjects, Z0 is taken 33 mm Hg
· L-1 · s2; to
calculate values for Z0 in patients, we
make use of the fact that Z0 varies in proportion
to 1/
C.9 L is a parameter that
represents the inertia of blood and is related to
arterial dimensions and blood density. We assume L=5
mm Hg · L-1 ·
s2 for control subjects and
patients.5
In the approximation of end-systolic aortic pressure with LV SBP, effective arterial elastance (Ea) is given as SBP/SV.10 For the control population, Ea=1510 mm Hg/L (1.51 mm Hg/mL). In normal subjects, the ratio of Ea and Emax is close to 1.11 We therefore assume Emax=1500 mm Hg/L in the control group. Further, LVEDV values are computed from given end-diastolic diameters and the minor/major hemiaxis ratio, with the assumption of an ellipsoidal model. With SV in each subgroup known, LV end-systolic volume (LVESV) can then be calculated as LVESV=LVEDV-SV. Emax is approximated as Emax=SBP/(LVESV-Vd). In solving this equation for Vd with appropriate values for controls (Emax=1500 mm Hg/L, SBP=124 mm Hg, and LVESV=29x10-3 L), Vd is estimated as -53.7x10-3 L in the control group. With Pv=5 mm Hg, Emin is calculated as Pv/(LVEDV+53.7), giving a value of 30 mm Hg/L (0.030 mm Hg/mL) in the control group.
To the best of our knowledge, there are no data on the variation of the intercept of the end-systolic pressure-volume relation in the different cardiac adaptation scenarios. Therefore, we use a constant Vd for all patient groups. Emax can then be calculated directly from the data reported by Ganau et al.3 Heart rate (70 bpm) and the timing of maximal contraction (tP=0.32 second) are taken as constant. The changes in LV volume and wall thickness have a similar effect on passive (Emin) and active (Emax) properties. We thus assume that Emin changes in proportion to Emax; Pv then follows from Emin, measured LVEDV, and Vd. The validity of the heartarterial model and the assumptions that lead to the model parameter setting is evaluated by comparing computed pressure and flow with the reported, measured values.
Contribution of Arterial and Cardiac Changes to Blood
Pressure in Hypertension
To study the individual contribution of alterations in cardiac
properties, arterial model parameters are given
the values assessed for the control group, whereas cardiac model
parameters are given the appropriate values that we
assessed in the hypertensive patients. Isolated changes in R (or C) are
studied in an analogous way, with control cardiac
parameters and control C (or R). The difference between the
control and the newly obtained hemodynamic data yields
the contribution of each individual parameter to SBP, PP,
and SV. We further consider combined changes in R and C to quantify the
overall contribution of arterial changes to SBP.
| Results |
|---|
|
|
|---|
|
|
Contribution of Arterial and Cardiac Changes to Blood
Pressure in Hypertension
In the group of hypertensives with normal LV, the data in Table 2 show modest alterations in R
(increase), C (decrease), and LV pump function
(Emax and Pv increase). R
and cardiac function both contribute positively to SBP; C has little
effect (Figure 3, top row). The increase
in R decreases PP, whereas the changes in C and pump function increase
PP. The increase in R lowers SV, whereas the increase in pump function
increases SV.
|
|
In the concentric remodeling group, R and LV pump function both increase, whereas C decreases (Table 2). The only parameter that contributes significantly to the increase in SBP is R (Figure 3, second row). The decrease in C has the greatest effect on PP (increase), whereas the increase in R has the greatest effect on SV (decrease).
In the concentric hypertrophy group, R and LV pump function have increased, whereas C has decreased (Table 2). The changes in cardiac function and R both contribute to the higher SBP (Figure 3, third row). The increase in R results in a lower PP and SV; the increase in pump function results in a higher PP and SV. The decrease in C increases PP and lowers SV.
In the eccentric hypertrophy group, only cardiac preload parameters change (Table 2). The increase in preload results in higher SBP, PP, and SV values (Figure 3, bottom row).
The mathematical model simulations indicate that in the normal LV group, the SBP increment is about equally due to arterial (46%) and cardiac (54%) remodeling (Figure 4). In the concentric remodeling group, arterial changes are the main factors that contribute to blood pressure (82%). In both the concentric and eccentric hypertrophy groups, cardiac geometric alterations are the main contributor to SBP and are responsible for 58% and 108% of the increase in SBP, respectively. The 108% increase in SBP in eccentric hypertrophy is due to the fact that the arterial changes have a small negative effect (-8%) on SBP.
|
| Discussion |
|---|
|
|
|---|
Parallel changes in arterial and cardiac structure and function have been observed.11 13 Roman et al14 studied carotid artery structure and function in the same 4 left ventricular phenotypes. They found that although blood pressure was the same in the concentric and eccentric hypertrophy groups, carotid artery dimensions, intima-media thickness, and stiffness were most abnormal in the concentric hypertrophy group.14 The data used for our simulations show reduced total arterial compliance in the concentric hypertrophy but also the concentric remodeling group (Table 2). SV was considerably lower in the latter group than in all others, leading to higher values for peripheral resistance and lower values for total arterial compliance. Unfortunately, Roman et al14 did not report SV, limiting a more detailed and direct comparison of both data sets.
The LV response to hypertension is a complex dynamic process, with mechanical, molecular, genetic, and biochemical factors involved.15 In the present study, we do not speculate on the mechanisms that trigger arterial or cardiac remodeling. We simply use reported arterial and cardiac mechanical parameters, measured at a particular moment during the disease process, to calculate their effect on blood pressure elevation. When possible, we determined mechanical properties directly from the data (R and C); other parameters were varied in a relative sense, starting from the parameters in the control group (Emin). There was a good agreement (Figure 2) between measured and predicted arterial pressure and flow, which supports that the model parameter values we used are correct. The only arbitrary parameter we entered was venous filling pressure in the control group. As LVEDV was measured, Pv determines the slope of the diastolic pressure-volume relation in the control group. In the patients, we assumed that changes in wall thickness and volume, changing Emax, proportionally affected diastolic stiffness. Together with measured LVEDV, we thus obtained estimations for the increase in venous filling pressure. Impaired diastolic function in LV hypertrophy has been described,16 17 and the elevated venous filling pressure in concentric hypertrophy is well documented in studies on chronic pressure overload of the heart.18 19
The outcome of the present study, however, does not depend on the assumptions we made on the diastolic filling properties of the LV. Our model couples the LV to the arterial load and is suitable to study LV systolic function. The preload parameters Emin and Pv are important because they yield LVEDV, the extent to which the LV is loaded at the onset of contraction. In the present study, however, we used the actual measured values for LVEDV; the choice of either Pv or Emin yields the other parameter through the definition of E(t), but their value is only indicative. For the same reason, the model is not suited to study the effects of impaired LV relaxation of LV filling hemodynamics.
Recently, much attention was paid to the role of vascular stiffening in hypertension.20 21 Our model predicts that compliance changes alone have a limited effect on SBP, confirming experimental results in isolated feline heart preparation22 and in the intact mammal.23 24 Randall et al23 concluded that compliance changes alone do not lead to (isolated systolic) hypertension. Kelly et al24 found a 47% increase in SBP after lowering compliance by 60% to 80%, but in their study, peripheral resistance (+17%) and venous filling pressure (+38%) were also increased, with both effects contributing to the elevation of blood pressure.
The classification of LV adaptation patterns allows a better characterization of the hypertensive population. It is, however, still unclear whether it provides a prognostic value in addition to LV mass.25 26 Our approach, which enables the quantification of vascular versus heart components to blood pressure on a per-patient basis, has the potential to lead to a better prognostic marker for cardiovascular risk.
The present mathematical model study has some inherent limitations. Both the heart and the arterial tree were simulated with linear models; thus, nonlinear properties were neglected. However, with appropriate model parameters, both models are good mechanical representations of both physiological systems, incorporating principal features of both.1 5 27 We compared aortic blood pressure, given by the model, with measured sphygmomanometer brachial blood pressure. Due to wave travel and wave reflection, SBP is higher in the brachial artery than in the aorta.9 Further, we assumed that an increase in contractility (Emax) proportionally affects passive diastolic filling properties (Emin). However, given the uncertainties in the assessment of these parameters and the fact that we studies relative differences between different groups, these assumptions do not affect the validity of our results. We also assumed a constant intercept (Vd) of the end-systolic pressure-volume relation. Especially in eccentric remodeling, where the LV pressure-volume loop is shifted to the right, this assumption may not hold. However, there still is a significant overlap with the pressure-volume loops measured or simulated in the control group. The rightward shift thus is much smaller than that seen in patients with cardiac failure, with severely dilated hearts and LVEDV in the range of 200 to 300x10-3 L,28 where Vd is expected significantly elevated.
In summary, we have shown that vascular stiffening widens the arterial pulse without increasing SBP. It is only in combination with an increased resistance that arterial remodeling can lead to hypertension. However, the most important contribution to blood pressure in hypertension comes from cardiac remodeling and, thus, altered pump function. Depending on the remodeling pattern, the cardiac contribution is responsible for 21% to 108% of the increase in SBP in hypertension.
| Acknowledgments |
|---|
Received January 19, 1999; first decision February 21, 2000; accepted May 10, 2000.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. E. Wagenseil, R. H. Knutsen, D. Y. Li, and R. P. Mecham Elastin-insufficient mice show normal cardiovascular remodeling in 2K1C hypertension despite higher baseline pressure and unique cardiovascular architecture Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H574 - H582. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Jimenez, C. Conde, A. Casanegra, C. Romero, A. Hugo Tabares, and M. Orias Association of ACE genotype and predominantly diastolic hypertension: a preliminary study Journal of Renin-Angiotensin-Aldosterone System, March 1, 2007; 8(1): 42 - 44. [Abstract] [PDF] |
||||
![]() |
D. Jegger, R. da Silva, X. Jeanrenaud, M. Nasratullah, H. Tevaearai, L. K. von Segesser, P. Segers, V. Gaillard, J. Atkinson, I. Lartaud, et al. Ventricular-arterial coupling in a rat model of reduced arterial compliance provoked by hypervitaminosis D and nicotine Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1942 - H1951. [Abstract] [Full Text] [PDF] |
||||
![]() |
A L Pauca, N D Kon, and M F O'Rourke Benefit of glyceryl trinitrate on arterial stiffness is directly due to effects on peripheral arteries Heart, November 1, 2005; 91(11): 1428 - 1432. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Mazzaro, S. J. Almasi, R. Shandas, D. R. Seals, and P. E. Gates Aortic Input Impedance Increases With Age in Healthy Men and Women Hypertension, June 1, 2005; 45(6): 1101 - 1106. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Garcia, P. J. C. Barenbrug, P. Pibarot, A. L. A. J. Dekker, F. H. van der Veen, J. G. Maessen, J. G. Dumesnil, and L.-G. Durand A ventricular-vascular coupling model in presence of aortic stenosis Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1874 - H1884. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Segers, D. Georgakopoulos, M. Afanasyeva, H. C. Champion, D. P. Judge, H. D. Millar, P. Verdonck, D. A. Kass, N. Stergiopulos, and N. Westerhof Conductance catheter-based assessment of arterial input impedance, arterial function, and ventricular-vascular interaction in mice Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1157 - H1164. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Y. Bagrov and E. G. Lakatta The Dietary Sodium-Blood Pressure Plot "Stiffens" Hypertension, July 1, 2004; 44(1): 22 - 24. [Full Text] [PDF] |
||||
![]() |
P. E. Gates, H. Tanaka, J. Graves, and D. R. Seals Left ventricular structure and diastolic function with human ageing: Relation to habitual exercise and arterial stiffness Eur. Heart J., December 2, 2003; 24(24): 2213 - 2220. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chemla, I. Antony, Y. Lecarpentier, and A. Nitenberg Contribution of systemic vascular resistance and total arterial compliance to effective arterial elastance in humans Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H614 - H620. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |